Loading news...
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
TransMedics, KORU Medical Systems and Cardinal Health beat the S&P 500 as execution, earnings visibility and company-specific catalysts drove gains.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Shares of Cardinal Health, Inc. (NYSE: CAH - Get Free Report) have been given an average rating of "Moderate Buy" by the sixteen brokerages that are covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 12-month
In the closing of the recent trading day, Cardinal Health (CAH) stood at $208.48, denoting a +1.47% move from the preceding trading day.
DUBLIN, Ohio, Jan. 6, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2026 on February 5, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.
CWA Asset Management Group LLC reduced its stake in shares of Cardinal Health, Inc. (NYSE: CAH) by 23.3% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 85,946 shares of the company's stock after selling 26,069 shares during the period. CWA Asset Management Group LLC's holdings
Cardinal Health (NYSE: CAH - Get Free Report) and Pro-Dex (NASDAQ: PDEX - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations and institutional ownership. Profitability This table compares Cardinal Health and Pro-Dex's net
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%), and CHRW (+61.22%) delivered strong double-digit returns. Dividend growth for the Aristocrats slowed to 5.52% in 2025, down from 5.78% in 2024, with 68 of 69 raising payouts.
AMZN, CAH, LRN and EAT stand out with strong interest coverage ratios to help weather 2026's shifting market tides.
Valley National Advisers Inc. decreased its holdings in shares of Cardinal Health, Inc. (NYSE: CAH) by 96.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 621 shares of the company's stock after selling 15,709 shares during the
Sowell Financial Services LLC trimmed its holdings in shares of Cardinal Health, Inc. (NYSE: CAH) by 39.3% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 15,419 shares of the company's stock after selling 9,987 shares during the quarter.
Columbus Macro LLC boosted its stake in shares of Cardinal Health, Inc. (NYSE: CAH) by 102.8% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 36,529 shares of the company's stock after purchasing an additional 18,516 shares during the period. Columbus Macro LLC's holdings in
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Four large-cap MedTech leaders, MDT, ISRG, CAH, EW, appear well-positioned to extend their winning streaks in 2026 on resilient procedure demand and innovation.
Board of the Pension Protection Fund lowered its holdings in Cardinal Health, Inc. (NYSE: CAH) by 83.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,700 shares of the company's stock after selling 8,400 shares during the quarter. Board of the
Cardinal Health (CAH) closed the most recent trading day at $202.95, moving +1.93% from the previous trading session.
Exploring the Fund's Recent Portfolio Adjustments Vanguard Health Care Fund (Trades, Portfolio) recently submitted its N-PORT filing for the third quarter of 2
Spotlight Innovation (OTCMKTS:STLT - Get Free Report) and Cardinal Health (NYSE: CAH - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership. Analyst Ratings This is a breakdown of recent